AstraZeneca
AZN
#43
Rank
HK$2.473 T
Marketcap
HK$1,596
Share price
-1.09%
Change (1 day)
42.05%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$41.71

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$41.81. In 2024 the company made an earnings per share (EPS) of HK$35.48 an increase over its 2023 EPS that were of HK$30.01.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$41.7117.56%
2024HK$35.4818.23%
2023HK$30.0181.13%
2022HK$16.57631.03%
2021HK$2.27-88.11%
2020HK$19.07136.89%
2019HK$8.05-39.41%
2018HK$13.29-28.27%
2017HK$18.52-14.37%
2016HK$21.6324.11%
2015HK$17.43127.55%
2014HK$7.66-51.96%
2013HK$15.94-58.95%
2012HK$38.84-32.2%
2011HK$57.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.04 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.52 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.63-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.30-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$179.89 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.14-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$85.88 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.10 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.21-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.45-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK